Due to its central enzymatic roles in the autophagy process, the cysteine protease ATG4B became one of the autophagy proteins being pursued as a potential therapeutic target [9,10], but little is known about its prognostic value in different cancers. This evidence concerns the gene ATG4B and cancer.